L-alanine supplementation in late infantile glycogen storage disease type II

Olaf A. Bodamer, Dorothea Haas, Monique M. Hermans, Arnold J. Reuser, Georg F. Hoffmann

Research output: Contribution to journalArticle

23 Scopus citations

Abstract

We report a male with late infantile glycogen storage disease type II (Pompe's disease) who presented at 12 months of age with muscular hypotonia and developmental delay. Oral supplementation with L-alanine has been administered for 5 years. Progression of skeletal myopathy was slow, and cardiomyopathy resolved almost completely. L-alanine may be a valuable supplement for infants with glycogen storage disease type II.

Original languageEnglish (US)
Pages (from-to)145-146
Number of pages2
JournalPediatric Neurology
Volume27
Issue number2
DOIs
StatePublished - Aug 2002

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Developmental Neuroscience
  • Clinical Neurology

Fingerprint Dive into the research topics of 'L-alanine supplementation in late infantile glycogen storage disease type II'. Together they form a unique fingerprint.

  • Cite this

    Bodamer, O. A., Haas, D., Hermans, M. M., Reuser, A. J., & Hoffmann, G. F. (2002). L-alanine supplementation in late infantile glycogen storage disease type II. Pediatric Neurology, 27(2), 145-146. https://doi.org/10.1016/S0887-8994(02)00413-7